1. Home
  2. KALV vs ALDF Comparison

KALV vs ALDF Comparison

Compare KALV & ALDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • ALDF
  • Stock Information
  • Founded
  • KALV N/A
  • ALDF 2024
  • Country
  • KALV United States
  • ALDF United States
  • Employees
  • KALV N/A
  • ALDF N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • ALDF
  • Sector
  • KALV Health Care
  • ALDF
  • Exchange
  • KALV Nasdaq
  • ALDF NYSE
  • Market Cap
  • KALV 362.2M
  • ALDF 296.6M
  • IPO Year
  • KALV N/A
  • ALDF 2024
  • Fundamental
  • Price
  • KALV $8.75
  • ALDF $9.96
  • Analyst Decision
  • KALV Strong Buy
  • ALDF
  • Analyst Count
  • KALV 7
  • ALDF 0
  • Target Price
  • KALV $27.00
  • ALDF N/A
  • AVG Volume (30 Days)
  • KALV 319.9K
  • ALDF 9.4K
  • Earning Date
  • KALV 03-10-2025
  • ALDF 01-01-0001
  • Dividend Yield
  • KALV N/A
  • ALDF N/A
  • EPS Growth
  • KALV N/A
  • ALDF N/A
  • EPS
  • KALV N/A
  • ALDF N/A
  • Revenue
  • KALV N/A
  • ALDF N/A
  • Revenue This Year
  • KALV N/A
  • ALDF N/A
  • Revenue Next Year
  • KALV N/A
  • ALDF N/A
  • P/E Ratio
  • KALV N/A
  • ALDF N/A
  • Revenue Growth
  • KALV N/A
  • ALDF N/A
  • 52 Week Low
  • KALV $7.30
  • ALDF $9.98
  • 52 Week High
  • KALV $16.88
  • ALDF $11.46
  • Technical
  • Relative Strength Index (RSI)
  • KALV 51.87
  • ALDF N/A
  • Support Level
  • KALV $7.30
  • ALDF N/A
  • Resistance Level
  • KALV $9.16
  • ALDF N/A
  • Average True Range (ATR)
  • KALV 0.41
  • ALDF 0.00
  • MACD
  • KALV 0.07
  • ALDF 0.00
  • Stochastic Oscillator
  • KALV 78.17
  • ALDF 0.00

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About ALDF ALDEL FINL II INC

Aldel Financial II Inc is a blank check company.

Share on Social Networks: